STOCK TITAN

National Resh Corp Stock Price, News & Analysis

NRC Nasdaq

Welcome to our dedicated page for National Resh news (Ticker: NRC), a resource for investors and traders seeking the latest updates and insights on National Resh stock.

NRC Health (National Research Corporation, NASDAQ: NRC) generates a steady stream of news focused on healthcare experience management, financial performance, and partnerships with health systems. This news page aggregates updates from company press releases, third-party announcements, and regulatory disclosures so readers can follow how NRC Health is working with healthcare organizations and how its business is evolving over time.

Many NRC Health news items highlight new and expanded partnerships with hospitals and health systems. Recent examples include collaborations with Mosaic Life Care, BJC Health System, North Mississippi Health Services, and South Shore Health. These announcements describe how NRC Health’s patient experience, employee experience, and market insight capabilities are being used to support human-centered care, unify feedback, and guide improvement across hospitals, clinics, and other care settings.

Investors and industry observers will also find coverage of NRC Health’s quarterly results, including revenue trends, Total Recurring Contract Value (TRCV), cash flow from operations, and non-GAAP measures such as Adjusted EBITDA and Adjusted Net Income. These earnings releases often include commentary from company leadership about sales activity, customer retention, and capital allocation through dividends and share repurchases.

Additional news includes leadership appointments, such as executive roles in finance and strategic insights, and recognition related to healthcare experience management, including references to the Best in KLAS Award for Healthcare Experience Management and Excellence in Patient Experience awards given by NRC Health to client organizations. Readers who want to monitor NRC Health’s role in healthcare experience improvement, its relationships with health systems, and its public company disclosures can use this page as a centralized source of updates.

Rhea-AI Summary

National Research Corporation (NASDAQ:NRC) has declared a quarterly cash dividend of $0.12 per share. This dividend will be payable on October 15, 2021, to shareholders of record by the close of business on September 30, 2021. NRC has established itself as a leading provider of analytics and insights to enhance human understanding for over 40 years, showcasing its commitment to shareholder returns.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.19%
Tags
dividends
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.28%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.4%
Tags
none
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.4%
Tags
none
-
Rhea-AI Summary

National Research Corporation reported strong Q2 2021 results, achieving a 17% revenue increase to $36.4 million and a 32% rise in operating income to $12.2 million. The total recurring contract value grew 5% to $149.8 million, driven by a 29% boost in Voice of the Customer offerings. The cash balance increased to $48.9 million. However, the effective tax rate rose to 25% from 10% in the previous year, impacting net income which reached $8.9 million, up from $7.7 million. The company focuses on organic growth and enhancing client relationships.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.03%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.35%
Tags
none
Rhea-AI Summary

National Research Corporation (NASDAQ:NRC) declared a quarterly cash dividend of $0.12 per share, payable July 15, 2021. Shareholders on record by June 30, 2021 will receive this dividend. With over 40 years of experience, NRC remains a leading provider of analytics and insights aimed at enhancing human understanding.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.54%
Tags
dividends
-
Rhea-AI Summary

NRC Health enhances its leadership with the appointment of Penny Wheeler, CEO of Allina Health, and Stephen Lockhart, former Chief Medical Officer of Sutter Health, to its Board of Directors, effective immediately. These seasoned executives bring extensive healthcare experience and a commitment to patient-centered care. CEO Michael Hays emphasized their potential to advance NRC Health's mission of 'Human Understanding' in healthcare. Wheeler and Lockhart expressed enthusiasm for contributing to NRC’s vision of personalized healthcare experiences, particularly for underserved communities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.14%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.15%
Tags
none
Rhea-AI Summary

National Research Corporation (NASDAQ: NRC) reported its Q1 2021 results, highlighting a 5% revenue increase to $35.5 million and a 7% rise in operating income to $12 million compared to Q1 2020. The company achieved a 19% growth in Voice of the Customer offerings and secured new clients such as Wake Forest Baptist Health. However, net income dropped to $9.2 million from $11.8 million year-over-year, leading to a decrease in diluted earnings per share from $0.46 to $0.36. Total operating expenses increased by 3% to $23.4 million, with notable rises in selling, general and administrative expenses.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.13%
Tags

FAQ

What is the current stock price of National Resh (NRC)?

The current stock price of National Resh (NRC) is $18.22 as of May 4, 2026.

What is the market cap of National Resh (NRC)?

The market cap of National Resh (NRC) is approximately 392.4M.